Kim
Lewis
University Distinguished Professor of Biology, Director of Antimicrobial Discovery Center
Kim Lewis in the Press
Quinoline tag helps vancomycin breach gram-negative defenses
“It’s genuinely surprising that the add-on gives vancomycin any ability at all to hit gram negatives,” says Kim Lewis, an antibiotic researcher at Northeastern University who was not involved in the study.
Nature.com
New antibiotic that kills drug-resistant bacteria discovered in technician’s garden
The molecule was found in soil samples collected from a laboratory technician’s garden. The discovery shows that “there is terrifically interesting stuff hiding in plain sight”, says Kim Lewis, a microbiologist at Northeastern University in Boston, Massachusetts, who was not involved in the research. “Kudos to them that they knew what to look for.”
Long Dismissed, Chronic Lyme Disease Is Finally Getting Its Moment
Kim Lewis, a biology professor at Northeastern University who researches Lyme disease, thinks that’s because the medical system isn’t comfortable with uncertainty.
Giant sloths and woolly mammoths: Mining past creatures’ DNA for future antibiotics
“Essentially, it’s a time machine,” said Kim Lewis, who develops new antibiotics at Northeastern University and is not involved in the work.
NBC News
Genetic study of Lyme disease bacteria offers clues to long-lasting symptoms
The new research is at a very early stage, but it is an important step to understanding and treating the disease, said Kim Lewis, a Lyme expert and a professor of biology at Northeastern University in Boston.
New bacterial ‘dark matter’ offers hope for a drug-resistant world
NovoBiotic Pharmaceuticals, founded by professors Kim Lewis and Slava Epstein from Northeastern University in Boston, has been tapping into that pool by collecting micro-organisms from soil samples, mimicking their natural environment in specially designed chambers, and so cultivating “domesticated” variants capable of growing in the lab.
Medical News Today
A new treatment for Lyme disease?
“Nobody really cared about that compound ever since because it’s very weak against regular bacteria,” says Prof. Kim Lewis, of Northeastern University College of Science, Boston, MA, and co-lead author of the present study. “What we discovered is that, yeah, it is very weak against regular pathogens, but exceptionally potent against spirochetes.”
Drug Target Review
New antibiotic a possible alternative to treat Lyme disease
Researchers at the Northeastern University in Boston and the University of Oklahoma, both US, have identified an antibiotic that may not only work to cure Lyme disease but may also help eradicate its occurrence from the environment.
Frontline
Explained: How researchers are trying to eradicate Lyme disease
Lyme disease may eventually be a thing of the past, says Kim Lewis, professor of biology and director of the Antimicrobial Discovery Center at Northeastern University in the U.S. city of Boston.
Deutsche Welle
Tackling Lyme disease: How researchers plan to disarm ticks
Lyme disease may eventually be a thing of the past, says Kim Lewis, professor of biology and director of the Antimicrobial Discovery Center at Northeastern University in the US city of Boston.
